Literature DB >> 16598589

Temporary trans-coronary pacing by coated guidewires: a safe and reliable method during percutaneous coronary intervention.

Konstantin M Heinroth1, Ina Stabenow, Ines Moldenhauer, Susanne Unverzagt, Michael Buerke, Karl Werdan, Roland Prondzinsky.   

Abstract

Relevant bradycardias during percutaneous coronary intervention (PCI) are a rare event, but they require immediate therapy by temporary pacing. However, transvenous pacing is associated with frequent and severe complications. Therefore, we wanted to evaluate the safety and reliability of trans-coronary pacing by means of a PCI guidewire. Coronary pacing was applied to 70 consecutive patients undergoing PCI. Pacing was performed before and after PCI in a unipolar setting using standard guidewires as a cathode and a skin electrode as an anode. Both were connected to an external pacemaker. Coronary pacing (maximum output at 10 V, impulse duration 2.5 ms) was effective in 60 of 70 patients (85.7%). Successful pacing was achieved in the LAD and diagonal branches in 90% (27 of 30 Pts.), in the LCX and marginal branches 84.2% (16 of 19 Pts.) and in the RCA in 81% (17 of 21 Pts.). Pacing thresholds were comparable in all vessels within a range of 1-10 V averaging 6.6 +/- 2.3 V before and 6.6 +/- 2.2 V after PCI. The impedance ranged from 190-544 Omega with mean pacing impedance for coronary pacing of 424 Omega before and 416 Omega after PCI, respectively. Significant bradycardias during PCI occurred in 7 cases (10%). In three cases (4.3%) temporary coronary pacing became necessary at a maximum pacing duration of 3 min. There were no severe side effects. Coronary spasm occurred in 3 cases (4.3%) after pacing and was promptly reversible after intracoronary application of nitroglycerine. It is concluded that coronary pacing is a safe and feasible method for the treatment of bradycardias during PCI. It avoids additional venous puncture under hemodynamically unstable conditions and subsequent transvenous pacing, which is accompanied by potentially severe complications and additional costs.

Entities:  

Mesh:

Year:  2006        PMID: 16598589     DOI: 10.1007/s00392-006-0361-3

Source DB:  PubMed          Journal:  Clin Res Cardiol        ISSN: 1861-0684            Impact factor:   5.460


  22 in total

1.  Successful recanalization of an occluded coronary artery by percutaneous coronary intervention, systemic administration of tirofiban, a glycoprotein IIb/IIIa inhibitor, and intracoronary thrombolysis with alteplase.

Authors:  W Meyners; S Peters; M Trümmel; B Koehler
Journal:  Z Kardiol       Date:  2004-05

2.  The use of temporary transvenous pacing catheters during percutaneous transluminal coronary angioplasty.

Authors:  E S Killeavy; J J Ferguson
Journal:  Tex Heart Inst J       Date:  1990

3.  Surgical treatment for right ventricular perforation caused by transvenous pacing electrodes: a report of three cases.

Authors:  M Asano; A Mishima; T Ishii; Y Takeuchi; Y Suzuki; T Manabe
Journal:  Surg Today       Date:  1996       Impact factor: 2.549

4.  Coronary and left ventricular pacing as standby in invasive cardiology.

Authors:  F de la Serna; B Meier; A K Pande; P Urban; J J Adatte; V P Moles; J P Killisch; J J Bodenmann; G Barcellona; P A Dorsaz
Journal:  Cathet Cardiovasc Diagn       Date:  1992-04

5.  Coronary pacing during percutaneous transluminal coronary angioplasty.

Authors:  B Meier; W Rutishauser
Journal:  Circulation       Date:  1985-03       Impact factor: 29.690

6.  [Emergency cardiac pacing via a coronary vessel during percutaneous coronary angioplasty].

Authors:  P Chatelain; B Meier; J Bélenger; J P Killisch; J N Cox; W Rutishauser
Journal:  Arch Mal Coeur Vaiss       Date:  1985-10

7.  Transcoronary cardiac pacing during myocardial ischemia.

Authors:  J R Laird; R Hull; K C Stajduhar; L T Weston; W Kufs; D C Wortham
Journal:  Cathet Cardiovasc Diagn       Date:  1993-10

8.  Temporary transvenous cardiac pacing: 6 years experience in one coronary care unit.

Authors:  N I Jowett; D R Thompson; J E Pohl
Journal:  Postgrad Med J       Date:  1989-04       Impact factor: 2.401

9.  Effectiveness of the glycoprotein IIb/IIIa antagonist abciximab during percutaneous coronary interventions (PCI) in clinical practice at a single high-volume center.

Authors:  R Zahn; B Fraiture; K-E Siegler; S Schneider; A K Gitt; K Seidl; A Gandjour; G Wendland; S Vogt; K W Lauterbach; J Senges
Journal:  Z Kardiol       Date:  2003-06

10.  Use of balloon flotation pacing catheters for prophylactic temporary pacing during diagnostic and therapeutic catheterization procedures.

Authors:  J R Harvey; R M Wyman; R G McKay; D S Baim
Journal:  Am J Cardiol       Date:  1988-11-01       Impact factor: 2.778

View more
  3 in total

1.  Perioperative antiplatelet therapy in patients at risk for coronary stent thrombosis undergoing noncardiac surgery.

Authors:  Boris Bigalke; Peter Seizer; Tobias Geisler; Stephan Lindemann; Meinrad Gawaz; Andreas E May
Journal:  Clin Res Cardiol       Date:  2009-03-13       Impact factor: 5.460

2.  The double guidewire approach for transcoronary pacing in a porcine model.

Authors:  K M Heinroth; S Unverzagt; D Mahnkopf; S Frantz; R Prondzinsky
Journal:  Med Klin Intensivmed Notfmed       Date:  2016-11-23       Impact factor: 0.840

3.  Trans-coronary pacing via Rota wire prevents bradycardia during rotational atherectomy: a case report.

Authors:  Hirofumi Kusumoto; Kasumi Ishibuchi; Katsuyuki Hasegawa; Satoru Otsuji
Journal:  Eur Heart J Case Rep       Date:  2022-01-13
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.